NCT02657408View on ClinicalTrials.gov

Clinical Trial to Assess Pharmacodynamic Effects on Segmental Endotoxin Induced Inflammatory Response of BI 1026706 Versus Placebo

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 11, 2016

Primary Completion Date

February 14, 2017

Study Completion Date

March 13, 2017

Conditions
Healthy
Interventions
DRUG

BI 1026706

DRUG

Placebo

Trial Locations (1)

30625

Fraunhofer ITEM, Hanover

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02657408 - Clinical Trial to Assess Pharmacodynamic Effects on Segmental Endotoxin Induced Inflammatory Response of BI 1026706 Versus Placebo | Biotech Hunter | Biotech Hunter